HLA-independent T cell receptors for targeting tumors with low antigen density
Jorge Mansilla‐Soto(Memorial Sloan Kettering Cancer Center), Michel Sadelain(Columbia University Irving Medical Center), Maria Sjöstrand(Memorial Sloan Kettering Cancer Center), Ronald C. Hendrickson(Memorial Sloan Kettering Cancer Center), Mohamad Hamieh(Inserm), Claire Hivroz(Inserm), Theodoros Giavridis(Memorial Sloan Kettering Cancer Center), Michelle Sætersmoen(Oslo University Hospital), Morgan Huse(Memorial Sloan Kettering Cancer Center), Isabelle Rivière(Memorial Sloan Kettering Cancer Center), Sjoukje J. C. van der Stegen(Chan Zuckerberg Initiative (United States)), Anton Dobrin(Memorial Sloan Kettering Cancer Center), Zeguo Zhao(Memorial Sloan Kettering Cancer Center), Justin Eyquem(Gladstone Institutes), Sascha Haubner(Memorial Sloan Kettering Cancer Center), Mathieu Maurin(Immunité et Cancer), Noémie Paillon(Inserm), Zhuoning Li(Memorial Sloan Kettering Cancer Center), Fella Tamzalit(American Association of Blood Banks), Matthew M. Miele(Memorial Sloan Kettering Cancer Center), Pieter L. Lindenbergh(Memorial Sloan Kettering Cancer Center), Andrés E. Zucchetti(National University of Rosario), Archana Iyer(Columbia University), Andreina Garcia Angus(Memorial Sloan Kettering Cancer Center), Judith Feucht(Memorial Sloan Kettering Cancer Center)
Cited by 184
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k
Gene therapy comes of age
|Science|2018|1.4k